Evaluate the main and interactional effects of risperidone and olanzapine on body mass index (BMI), other measures of obesity, and other health-related factors, including total cholesterol, lipid panels, blood glucose, glycohemoglobin, and prolactin
Determine primary drug treatment effects and the relationships between change in BMI (body mass index), the biological measures listed above, and clinical outcomes including several domains of functioning.
18 Years to 60 Years (Adult)
September 15, 2005
August 26, 2008
Psychiatric Hospital at Vanderbilt Nashville, Tennessee, United States
† Study has passed its completion date and status has not been verified in more than two years.